JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Vanguard Russell 2000 ETF
VTWO
$17.4B
| $1.3M | ﹤0.01% |
26,002
| – | – |
|
2977
Old National Bancorp
ONB
$10.1B
| $1.3M | ﹤0.01% |
89,945
+586
| +0.7% | +$8.25K |
|
|
SD
2978
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $1.3M | ﹤0.01% |
1,479,340
+1,468,428
| +13,457% | +$2.16M |
|
|
NBIS
2979
Nebius Group N.V.
NBIS
$47.8B
| $1.29M | ﹤0.01% |
84,961
-309,312
| -78% | -$5.65M |
|
|
SNBR
2980
DELISTED
Sleep Number
SNBR
| $1.29M | ﹤0.01% |
42,971
-1,476
| -3% | -$46.7K |
|
2981
Tandem Diabetes Care
TNDM
$1.3B
| $1.29M | ﹤0.01% |
11,896
+6,756
| +131% | +$840K |
|
|
ERUS
2982
DELISTED
iShares MSCI Russia ETF
ERUS
| $1.29M | ﹤0.01% |
45,730
+32,954
| +258% | +$978K |
|
|
LBAI
2983
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.29M | ﹤0.01% |
108,396
+2,600
| +2% | +$30.2K |
|
|
IHS
2984
CALL
DELISTED
IHS INC CL-A COM STK
IHS
| $1.29M | ﹤0.01% |
+10,000
| New | +$1.25M |
|
2985
Energy Recovery
ERII
$435M
| $1.28M | ﹤0.01% |
468,999
-12,621
| -3% | -$37K |
|
2986
First Trust United Kingdom AlphaDEX Fund
FKU
$39M
| $1.28M | ﹤0.01% |
29,540
+1,328
| +5% | +$57.9K |
|
2987
PUT
Herc Holdings
HRI
$4.88B
| $1.28M | ﹤0.01% |
23,490
+18,490
| +370% | +$1.14M |
|
|
GBNK
2988
DELISTED
Guaranty Bancorp
GBNK
| $1.28M | ﹤0.01% |
77,350
+2,950
| +4% | +$48.8K |
|
|
FNI
2989
DELISTED
First Trust Chindia ETF
FNI
| $1.27M | ﹤0.01% |
41,619
+10,184
| +32% | +$320K |
|
2990
First Trust Germany AlphaDEX Fund
FGM
$99.1M
| $1.27M | ﹤0.01% |
33,607
+2,876
| +9% | +$112K |
|
|
RSE
2991
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $1.27M | ﹤0.01% |
77,773
-494
| -0.6% | -$8.63K |
|
2992
Banco Bilbao Vizcaya Argentaria
BBVA
$152B
| $1.27M | ﹤0.01% |
135,113
-1,051,399
| -89% | -$10.2M |
|
2993
CALL
AB InBev
BUD
$166B
| $1.27M | ﹤0.01% |
+10,500
| New | +$1.29M |
|
|
CYBX
2994
DELISTED
CYBERONICS INC
CYBX
| $1.26M | ﹤0.01% |
21,263
-111,587
| -84% | -$7.03M |
|
2995
H.B. Fuller
FUL
$2.98B
| $1.26M | ﹤0.01% |
31,065
-1,100
| -3% | -$46.5K |
|
2996
iShares US Utilities ETF
IDU
$1.36B
| $1.26M | ﹤0.01% |
24,312
+1,514
| +7% | +$83.2K |
|
|
PGI
2997
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $1.26M | ﹤0.01% |
+122,474
| New | +$1.24M |
|
2998
First Trust Switzerland AlphaDEX Fund
FSZ
$37.1M
| $1.26M | ﹤0.01% |
31,332
+2,096
| +7% | +$87.9K |
|
2999
Spok Holdings
SPOK
$225M
| $1.25M | ﹤0.01% |
74,256
-1,789
| -2% | -$32.7K |
|
|
CX.WS.B
3000
PUT
DELISTED
CEMEX S.A. ADS WTS (NEW)
CX.WS.B
| $1.25M | ﹤0.01% |
136,476
+113,596
| +496% | +$1.04M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.